Xtandi Alternatives Compared
| Xtandi (enzalutamide) | Pluvicto (lutetium lu 177 vipivotide tetraxetan) | Bicalutamide |
|
|---|
| Xtandi (enzalutamide) | Pluvicto (lutetium lu 177 vipivotide tetraxetan) | Bicalutamide |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Xtandi is an androgen receptor inhibitor that is usually used in conjunction with androgen deprivation therapy for the treatment of prostate cancer. The main side effects are weakness or lack of... View more |
Prescription only
Prescribed for Prostate Cancer. Pluvicto may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Prostate Cancer. Bicalutamide may also be used for purposes not listed in this medication guide. |
Related suggestions Prostate Cancer
|
|||||||||||||||||||||||
| More about Xtandi (enzalutamide) | More about Pluvicto (lutetium lu 177 vipivotide tetraxetan) | More about Bicalutamide | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Xtandi has an average rating of 5.8 out of 10 from a total of 22 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 41% reported a negative effect. |
Pluvicto has an average rating of 6.8 out of 10 from a total of 5 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 0% reported a negative effect. |
Bicalutamide has an average rating of 8.4 out of 10 from a total of 13 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Xtandi side effects |
View all Pluvicto side effects |
View all Bicalutamide side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Xtandi prices |
View all Pluvicto prices |
View all Bicalutamide prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
N/A |
Casodex | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
244.8 hours |
41.6 hours |
240 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 682 drugs are known to interact with Xtandi:
|
A total of 220 drugs are known to interact with Pluvicto:
|
A total of 384 drugs are known to interact with Bicalutamide:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
August 31, 2012 |
March 23, 2022 |
October 04, 1995 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.